Amgen Inc

[On Demand]
Search General Info
Search Education
Search Partnering Companies
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies and has reached millions of patients globally.
Ticker:
AMGN
Exchange:
NASDAQ
Company Type:
Publicly Traded Company
Company Website:
Company HQ State:
California
Company HQ Country:
United States
Year Founded:
1980
Main Therapeutic Focus:
Lead Product in Development:
LUMAKRAS (sotorasib)
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
photo
Vice President, Alliance & Integration Management
Amgen Inc.